cystamine has been researched along with Muscular Dystrophy, Oculopharyngeal in 1 studies
Muscular Dystrophy, Oculopharyngeal: An autosomal dominant hereditary disease that presents in late in life and is characterized by DYSPHAGIA and progressive ptosis of the eyelids. Mutations in the gene for POLY(A)-BINDING PROTEIN II have been associated with oculopharyngeal muscular dystrophy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davies, JE | 1 |
| Rose, C | 1 |
| Sarkar, S | 1 |
| Rubinsztein, DC | 1 |
1 other study available for cystamine and Muscular Dystrophy, Oculopharyngeal
| Article | Year |
|---|---|
Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy.
Topics: Animals; Apoptosis; Biomarkers; Cell Line; Cystamine; Cytoprotection; Disease Models, Animal; Gene K | 2010 |